Officials for retailer Claire's filed for bankruptcy protection on Wednesday as its operating costs rise while demand for its ...

Following the sale of the direct-to-consumer genetic testing company 23andMe, the Utah Attorney General’s Office is issuing a ...

Bar K, a dog bar chain, said on Tuesday, July 29 it is closing all three of its locations in St. Louis, Kansas City and Oklahoma City.

We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Regeneron Pharmaceuticals, Inc.

A federal judge on Thursday declined to block the bankruptcy sale of genetic testing company 23andMe to its co-founder Anne Wojcicki pending the outcome of a legal challenge by California.

A bankruptcy judge has approved the sale of 23andMe to a new buyer, TTAM Research Group, a nonprofit led by Anne Wojcicki, the former CEO and co-founder of the company.

Anne Wojcicki's nonprofit, TTAM Research Institute, has received court approval to acquire 23andMe, the genetic testing company she co-founded ...

Despite Regeneron's pledges to honor 23andMe's privacy policies, more than two dozen states sued to halt the deal, arguing that genetic information is a unique and fundamentally different type of ...

Genetic testing company 23andMe never hit on a sustainable business model and went bankrupt. Now, it's being sold to a non-profit launched by the co-founder, delaying addressing data privacy concerns.

Regeneron will now serve as the “backup bidder” pending court approval and the deal’s closing, which is expected in the “coming weeks,” 23andMe said.

23andMe co-founder and CEO Anne Wokcicki won back control of the genetic-test company after a prolonged bankruptcy fight that at one point was won by Regeneron.